Quidel News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.01.19	Quidel to Present at 37th Annual J.P. Morgan Healthcare Conference (Businesswire)
20.12.18	Quidel Receives CE Mark for Its Point-of-Care Sofia® Quantitative Vitamin D Assay for Use With Sofia Instrument (Businesswire)
19.12.18	Quidel Receives CE Mark for Point-of-Care Sofia® 2 Lyme+ Fluorescent Immunoassay for Use with Sofia 2 Instrument (Businesswire)
13.12.18	Quidel Announces the Availability of Triage® PLGF Assay for Use with Quidel’s Triage® MeterPro Instrumented System (Businesswire)
08.12.18	Quidel to Hold BNP Supply Agreement Update Conference Call on December 10, 2018 (Businesswire)
07.12.18	Quidel Comments on California Court Ruling (Businesswire)
12.11.18	Quidel to Present at the 30th Annual Piper Jaffray Healthcare Conference (Businesswire)
06.11.18	Quidel Reports Third Quarter 2018 Financial Results (Businesswire)
17.10.18	Quidel to Hold Third Quarter 2018 Financial Results Conference Call on November 6th, 2018 (Businesswire)
31.08.18	Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument from Finger-Stick Whole Blood Specimens (Businesswire)
07.08.18	Quidel Reports Second Quarter 2018 Financial Results (Businesswire)
17.07.18	Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018 (Businesswire)
17.07.18	EOLS Slumps On Stock Offering, BLCM CFO To Exit, NVRO Trims Revenue Outlook (RTTNews)
16.07.18	Quidel Receives FDA Clearance for Solana® Bordetella Complete® Molecular Diagnostic Assay for the Detection of Pertussis (Whooping Cough), Parapertussis Infections (Businesswire)
05.06.18	Quidel to Present at William Blair 38th Annual Growth Stock Conference (Businesswire)
01.06.18	Quidel Announces Private Exchange Transactions (Businesswire)
15.05.18	Quidel to Present at UBS Global Healthcare Conference (Businesswire)
08.05.18	Quidel Reports First Quarter 2018 Financial Results (Businesswire)
23.04.18	Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018 (Businesswire)
27.03.18	Quidel to Host 2018 Analyst and Investor Day in Chicago (Businesswire)
09.03.18	Quidel Announces Private Exchange Transactions (Businesswire)
05.03.18	Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument (Businesswire)
26.02.18	Quidel to Present at Upcoming Conferences (Businesswire)
21.02.18	Quidel Reports Fourth Quarter and Full Year 2017 Financial Results (Businesswire)
14.02.18	TTPH Implodes On IGNITE3, EC Approves 2nd Herceptin Biosimilar, PTIE At It Again (RTTNews)
14.02.18	Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements (Businesswire)
08.02.18	Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018 (Businesswire)
05.01.18	Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million (Businesswire)
22.12.17	Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Strep A+ Assay (Businesswire)
22.12.17	Quidel Receives FDA Clearance for Its New Solana® Molecular Assay for the Detection of Group B Streptococcal Infections (Businesswire)
22.12.17	Quidel to Present at 36th Annual J.P. Morgan Healthcare Conference (Businesswire)
19.12.17	Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses (Businesswire)
14.12.17	Quidel Announces Timing of Filing of Form 8-K/A To Report Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses (Businesswire)
28.11.17	CDNA, ALNA Up On Analyst Coverage, LIFE Goes Ahead, GLYC Gearing Up For ASH (RTTNews)
15.11.17	Quidel to Present at the 29th Annual Piper Jaffray Healthcare Conference (Businesswire)
22.09.17	Versartis Loses VELOCITY - What Other Pharma Stocks Made News This Week? (RTTNews)
20.09.17	CAPR Is Hot, VBLT In Rally Mode, MYOK's Data Heartening, MediWound Bleeds (RTTNews)
19.09.17	NBRV Leaps On Study Data, CSII Takes A Hit, CLVS Abuzz, New Dimension For DMTX (RTTNews)
19.07.17	Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH... (RTTNews)
18.07.17	Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN... (RTTNews)
17.07.17	Quidel To Buy Alere Triage Assets (RTTNews)
30.11.16	Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (RTTNews)
30.11.16	Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (RTTNews)
24.06.15	EYES Turns Vision Into Reality, QDEL Gets FDA Nod, Watch Out For ADHD (RTTNews)
24.04.15	AERI's Rocket-1 Crashes, ACT Launches Avycaz, DRNA Extends Gain After Hours (RTTNews)
03.12.14	Quidel Announces Pricing Of $150 Mln Convertible Senior Notes Offering (RTTNews)
21.10.14	Quidel Posts Q3 Non-GAAP Loss Per Share Of $0.01 - Quick Facts (RTTNews)
15.10.14	FDA Clears Quidel's Lyra Parainfluenza Assay (RTTNews)
14.10.14	ABBV Seeks New Cures From Old Drug, RARE Findings, Nanosphere Makes Giant Leap (RTTNews)
26.08.14	ArborGen Names John Radak CFO - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	3’940.00	1.81 %	K V
Roche Hldg G	269.30	1.58 %	K V
Lonza Grp	588.60	1.38 %	K V
Novartis	94.08	0.73 %	K V
Swisscom	546.00	0.65 %	K V
Sonova Hldg	251.30	0.08 %	K V
CieFinRichemont	146.90	-0.24 %	K V
Kuehne+Nagel Int	188.30	-0.26 %	K V
Swiss Re	144.35	-0.35 %	K V
ABB	42.73	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Quidel Aktie VALOR 964934 / ISIN US74838J1016

Nachrichten zu Quidel Corp.

Aktien Top/Flop

Quidel Peer Group Nachrichten

Meistgelesene Nachrichten